Share

Videos

Barron's Bounce: Pitney Bowes Moves Higher

The Wall Street Journal
|
May 19, 2014 AT 2:18 PM
Why a mail machine company is a good investment. Plus: TD Ameritrade is benefiting from the return of the retail investor, and Pfizer is better off without AstraZeneca.